Gilead Sciences | GILD - Capitalisation Boursière





Capitalisation Boursière Changement Date
AbbVie USD 444.6B 59.91B 2026-06
ALKERMES USD 8.73B 2.85B 2026-06
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amgen USD 195.44B 5.55B 2026-06
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 1.13T 260.54B 2026-06
Gilead Sciences USD 156.86B 16.13B 2026-06
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Glaxosmithkline GBP 109.29B 9.36B 2026-03
Incyte USD 22.65B 3.92B 2026-06
J&J USD 611.36B 32.21B 2026-06
Merck USD 317.37B 20.27B 2026-06
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
United Therapeutics USD 23B 2.19B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06